This inventor holds 2 USPTO granted patents and 5 published patent applications and 1 EPO patent. Top assignees: Centre National De La Recherche Scientifique, National Institute of Health and Medical Research, Universitë De Bordeaux. Active years: 2020-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 5,383 
2 out of 1,853 
2 out of 226 
Years Active: 2020-2021
Title: Marie-Aline Andreola: Innovator in Antiviral Research
Introduction
Marie-Aline Andreola is a prominent inventor based in Bordeaux, France. She has made significant contributions to the field of antiviral research, particularly through her work on porphyrin derivatives. With a total of two patents to her name, her innovations are paving the way for new treatments against viral infections.
Latest Patents
Marie-Aline Andreola's latest patents focus on derivatives of porphyrins and their applications in treating viral infections. The first patent details metallated porphyrin derivatives as ligands of G-quadruplex, highlighting their novel use as anti-viral agents. This innovative approach aims to provide new therapeutic options for combating viral diseases.
Career Highlights
Throughout her career, Marie-Aline has worked with esteemed institutions such as the Institut National de la Santé et de la Recherche Médicale and the Centre National de la Recherche Scientifique. Her research has garnered attention for its potential impact on public health and the treatment of viral infections.
Collaborations
Marie-Aline has collaborated with notable colleagues, including Samir Amrane and Geneviève Pratviel. These partnerships have enriched her research and contributed to the advancement of her innovative projects.
Conclusion
Marie-Aline Andreola stands out as a key figure in the field of antiviral research, with her groundbreaking work on porphyrin derivatives. Her contributions are essential in the ongoing fight against viral infections, showcasing the importance of innovation in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile